Pegylated-Interferon-a-2a plus Tenofovir or Placebo for the treatment of hepatitis delta: First results of the HIDIT-2 study
dc.contributor.author | Yurdaydın, Cihan | |
dc.contributor.author | Wedemeyer, Heiner | |
dc.contributor.author | Caruntu, Florin A. | |
dc.contributor.author | Curescu, Manuela G. | |
dc.contributor.author | Yalçın, Kendal | |
dc.contributor.author | Akarca, Ulus S. | |
dc.contributor.author | Zeuzem, Stefan | |
dc.contributor.author | Erhardt, Andreas | |
dc.contributor.author | Lueth, Stefan | |
dc.contributor.author | Papatheodoridis, George V. | |
dc.contributor.author | Port, Kerstin | |
dc.contributor.author | Keskin, Onur | |
dc.contributor.author | Radu, Monica N. | |
dc.contributor.author | Çelen, Mustafa K. | |
dc.contributor.author | İdilman, Ramazan | |
dc.contributor.author | Stift, Judith | |
dc.contributor.author | Mederacke, Ingmar | |
dc.contributor.author | Heidrich, Benjamin | |
dc.contributor.author | Manns, Michael P. | |
dc.contributor.author | Dienes, Hans Peter | |
dc.contributor.buuauthor | Gürel, Selim | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-7279-2161 | tr_TR |
dc.contributor.researcherid | EYK-5719-2022 | tr_TR |
dc.date.accessioned | 2022-09-29T07:33:02Z | |
dc.date.available | 2022-09-29T07:33:02Z | |
dc.date.issued | 2012-10 | |
dc.description | Bu çalışma, 9-13 Kasım 2012 tarihleri arasında Boston[ABD]'da düzenlenen 63. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)'de bildiri olarak sunulmuştur. | en_US |
dc.description.sponsorship | Amer Association of Study Liver Diseases | en_US |
dc.identifier.citation | Yurdaydın, C. vd. (2012). "Pegylated-Interferon-a-2a plus Tenofovir or Placebo for the treatment of hepatitis delta: First results of the HIDIT-2 study". Hepatology, 56, Supplement 1, 202A-203A. | en_US |
dc.identifier.endpage | 203A | tr_TR |
dc.identifier.issn | 0270-9139 | |
dc.identifier.issue | Supplement 1 | en_US |
dc.identifier.startpage | 202A | tr_TR |
dc.identifier.uri | https://aasldpubs.onlinelibrary.wiley.com/loi/15273350/year/2012 | |
dc.identifier.uri | http://hdl.handle.net/11452/28877 | |
dc.identifier.volume | 56 | tr_TR |
dc.identifier.wos | 000310955601024 | |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.collaboration | Yurt dışı | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.relation.journal | Hepatology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Gastroenterology & hepatology | en_US |
dc.subject.wos | Gastroenterology & hepatology | en_US |
dc.title | Pegylated-Interferon-a-2a plus Tenofovir or Placebo for the treatment of hepatitis delta: First results of the HIDIT-2 study | en_US |
dc.type | Meeting Abstract | |
dc.wos.quartile | Q1 | tr_TR |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: